ECSP084358A - NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA - Google Patents
NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONAInfo
- Publication number
- ECSP084358A ECSP084358A EC2008004358A ECSP084358A ECSP084358A EC SP084358 A ECSP084358 A EC SP084358A EC 2008004358 A EC2008004358 A EC 2008004358A EC SP084358 A ECSP084358 A EC SP084358A EC SP084358 A ECSP084358 A EC SP084358A
- Authority
- EC
- Ecuador
- Prior art keywords
- solid forms
- estra
- dien
- mesoprogestine
- hydroxyiminometil
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 4
- -1 hydroxyiminomethyl Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 238000002657 hormone replacement therapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000002923 oximes Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
El invento se refiere a las nuevas formas sólidas de la mesoprogestina 11 -[4E-(hidroxiiminometil)-fenil]-17 -metoxi-metil-17 -metoxi-estra-4,9-dien-3-ona (oxima J 867), especialmente a una forma extrapura y estable, amorfa o extracristalina (forma no solvatada (no solvato)/no hidrato), del compuesto J 867, a un método para su preparación y a su uso en composiciones farmacéuticas.Las nuevas formas sólidas se caracterizan especialmente por su alta estabilidad. Estas formas sólidas de la oxima J867 pueden utilizarse especialmente en el control de la fertilidad y en la terapia de reemplazo hormonal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00110887A EP1157996A1 (de) | 2000-05-23 | 2000-05-23 | Neue Festkörperformen des Mesoprogestins 11Beta-[4E-(Hydroxyiminomethyl)-phenyl]-17Alpha-methoxymethyl-17Beta-methoxy-estra-4,9-dien-3-on |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP084358A true ECSP084358A (es) | 2008-11-27 |
Family
ID=8168805
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004358A ECSP024358A (es) | 2000-05-23 | 2002-11-22 | Nuevas fomas solidas de la meso´rogestina 11beta(4e-hidroxiiminometil)-fenil) 17 alfa-metoximetil-17 beta-metoxi-estra-4,9 -dien-3-ona |
| EC2008004358A ECSP084358A (es) | 2000-05-23 | 2008-10-22 | NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004358A ECSP024358A (es) | 2000-05-23 | 2002-11-22 | Nuevas fomas solidas de la meso´rogestina 11beta(4e-hidroxiiminometil)-fenil) 17 alfa-metoximetil-17 beta-metoxi-estra-4,9 -dien-3-ona |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7799770B2 (es) |
| EP (3) | EP1157996A1 (es) |
| JP (1) | JP2003534350A (es) |
| KR (1) | KR100553292B1 (es) |
| CN (1) | CN100384867C (es) |
| AT (1) | ATE397617T1 (es) |
| AU (2) | AU2001256344B2 (es) |
| BG (1) | BG65968B1 (es) |
| BR (1) | BR0111058A (es) |
| CA (1) | CA2409869C (es) |
| CZ (1) | CZ2003620A3 (es) |
| DE (1) | DE50114012D1 (es) |
| DK (1) | DK1292607T3 (es) |
| EA (1) | EA005623B1 (es) |
| EC (2) | ECSP024358A (es) |
| ES (1) | ES2307613T3 (es) |
| HR (2) | HRP20021032B1 (es) |
| HU (1) | HUP0301956A3 (es) |
| IL (2) | IL152868A0 (es) |
| ME (1) | MEP15608A (es) |
| MX (1) | MXPA02011524A (es) |
| NO (1) | NO327004B1 (es) |
| NZ (1) | NZ522768A (es) |
| PL (1) | PL358789A1 (es) |
| PT (1) | PT1292607E (es) |
| RS (1) | RS50493B (es) |
| SK (1) | SK2922003A3 (es) |
| UA (1) | UA73988C2 (es) |
| WO (1) | WO2001090137A2 (es) |
| ZA (1) | ZA200209322B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10218107A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| DE10218109A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| US20060173068A1 (en) * | 2005-01-18 | 2006-08-03 | Judith Aronhime | Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| DE102006018888A1 (de) * | 2006-04-18 | 2007-10-25 | Bayer Schering Pharma Ag | Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil) |
| US20090054387A1 (en) * | 2006-04-18 | 2009-02-26 | Detlef Grawe | Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) |
| EP1862468A1 (de) * | 2006-06-02 | 2007-12-05 | Bayer Schering Pharma Aktiengesellschaft | Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on |
| DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034362A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034525A1 (de) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19610667C2 (de) * | 1996-03-08 | 1998-04-09 | Schering Ag | (Z)-11ß-[4-(Dimethylamino)phenyl]17ß-hydroxy-17alpha-(3-hydroxy-1-propenyl)estr-4-en-3-on als kristallines Ansolvat |
| WO2001009116A2 (en) * | 1999-07-29 | 2001-02-08 | Eli Lilly And Company | A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
-
2000
- 2000-05-23 EP EP00110887A patent/EP1157996A1/de not_active Withdrawn
-
2001
- 2001-05-09 CA CA002409869A patent/CA2409869C/en not_active Expired - Lifetime
- 2001-05-09 DK DK01929632T patent/DK1292607T3/da active
- 2001-05-09 DE DE50114012T patent/DE50114012D1/de not_active Expired - Lifetime
- 2001-05-09 ES ES01929632T patent/ES2307613T3/es not_active Expired - Lifetime
- 2001-05-09 CZ CZ2003620A patent/CZ2003620A3/cs unknown
- 2001-05-09 MX MXPA02011524A patent/MXPA02011524A/es active IP Right Grant
- 2001-05-09 AU AU2001256344A patent/AU2001256344B2/en not_active Ceased
- 2001-05-09 PT PT01929632T patent/PT1292607E/pt unknown
- 2001-05-09 EP EP01929632A patent/EP1292607B1/de not_active Expired - Lifetime
- 2001-05-09 KR KR1020027015762A patent/KR100553292B1/ko not_active IP Right Cessation
- 2001-05-09 EA EA200201192A patent/EA005623B1/ru not_active IP Right Cessation
- 2001-05-09 US US10/296,463 patent/US7799770B2/en active Active
- 2001-05-09 SK SK292-2003A patent/SK2922003A3/sk not_active Application Discontinuation
- 2001-05-09 AU AU5634401A patent/AU5634401A/xx active Pending
- 2001-05-09 ME MEP-156/08A patent/MEP15608A/xx unknown
- 2001-05-09 NZ NZ522768A patent/NZ522768A/en unknown
- 2001-05-09 AT AT01929632T patent/ATE397617T1/de not_active IP Right Cessation
- 2001-05-09 HU HU0301956A patent/HUP0301956A3/hu unknown
- 2001-05-09 JP JP2001586324A patent/JP2003534350A/ja active Pending
- 2001-05-09 WO PCT/EP2001/005237 patent/WO2001090137A2/de active Application Filing
- 2001-05-09 EP EP07115136A patent/EP1862469A2/de not_active Withdrawn
- 2001-05-09 PL PL01358789A patent/PL358789A1/xx not_active IP Right Cessation
- 2001-05-09 CN CNB018099394A patent/CN100384867C/zh not_active Expired - Fee Related
- 2001-05-09 RS YUP-887/02A patent/RS50493B/sr unknown
- 2001-05-09 IL IL15286801A patent/IL152868A0/xx unknown
- 2001-05-09 BR BR0111058-6A patent/BR0111058A/pt not_active IP Right Cessation
- 2001-09-05 UA UA20021210147A patent/UA73988C2/uk unknown
-
2002
- 2002-11-14 IL IL152868A patent/IL152868A/en not_active IP Right Cessation
- 2002-11-15 ZA ZA200209322A patent/ZA200209322B/en unknown
- 2002-11-22 NO NO20025613A patent/NO327004B1/no not_active IP Right Cessation
- 2002-11-22 EC EC2002004358A patent/ECSP024358A/es unknown
- 2002-12-23 HR HR20021032A patent/HRP20021032B1/xx not_active IP Right Cessation
-
2003
- 2003-02-14 BG BG107557A patent/BG65968B1/bg unknown
-
2008
- 2008-08-29 HR HR20080423A patent/HRP20080423A2/xx not_active Application Discontinuation
- 2008-10-22 EC EC2008004358A patent/ECSP084358A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP084358A (es) | NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA | |
| HK1056181A1 (zh) | 作為抗炎劑的17β-硫代羧酸酯17α-芳基羰氧基氧雄甾烷衍生物 | |
| EA200201000A1 (ru) | Гормон-заместительная терапия | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| PT102548A (pt) | Formulacao farmaceutica para administracao por injeccao do composto 7alfa-¬9-(4,4,5,5,5-pentafluoropentilsulfinil)-nonil| estra-1,3,5(10)-trieno-3,17beta-diol (fulvestrant) | |
| EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
| MEP37608A (en) | Contraception process and administration form for the same | |
| BRPI0116793B8 (pt) | produtos de hormônio de esteróide e métodos para prepará-los | |
| ZA200308809B (en) | Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins. | |
| HRP20050173A2 (en) | Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition | |
| DK1328276T3 (da) | Anvendelse af antiprogestiner til profylakse og behandling af hormonafhængige sygdomme | |
| AP2003002716A0 (en) | Medicinal compositions containing propenone derivatives. | |
| HN2000000056A (es) | Nuevas formas cristalinas de un antibiotico macrolido | |
| PE20010579A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos | |
| HUP0301461A2 (hu) | 17 alfa-fluoralkil szteroidok alkalmazása a tumorsejtek növekedési faktor függésének gátlására szolgáló gyógyszerkészítmény előállítására | |
| PE20010581A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (hrt) | |
| CL2004001317A1 (es) | Composicion farmaceutica que comprende el antagonista de receptores de progesterona 11b-(4-acetilfenil)-17b-hidroxi-17 alfa-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-ona y un antiestrogeno puro; y su uso para tratar una enfermedad dependiente de h | |
| DK1652526T3 (da) | Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse | |
| ECSP034549A (es) | Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro | |
| AU2003280232A1 (en) | Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action | |
| BR0107724A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica e, uso de um composto | |
| PE20020752A1 (es) | Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena | |
| ECSP993196A (es) | Composiciones de isotretinoina y proceso para su produccion | |
| NO20025201L (no) | 19-nor-17<alfa>-pregna-1,3,5(10)-trien-17<beta>-oler med en 21,16<alfa>-laktonring | |
| WO2002101014A3 (en) | A process for making estra-4,9(10)-diene steroids |